Platelet function was studied in CPD whole blood stored at 4QC for one and three days and in platelet concentrates stored at room temperature for the same periods of time. Comparisons were made of platelet shape, nucleotide content, (3-thromboglobulin ((3TO) liberated during storage, and platelet aggregation in response to ADP, collagen, sodium arachidonate and ristocetin. It was found that in whole blood the shape of the platelets was less discoid than in platelet concentrates. However, platelet aggregation in response to ADP, collagen, and sodium arachidonate was preserved better in whole blood than in platelet concentrates. Platelet nucleotides were the same in whole blood as in platelet concentrates, but the plasma levels of (3 TO were less in whole blood. The results show that as judged by aggregation, (3 TO release and nucleotide content, platelets from whole blood were at least as functional as those from platelet concentrates. However, platelets from whole blood had lost their discoid shape, which suggests that they would have a short survival in the circulation.
Nielson and Mad~en found that 45070 of the platelets could be recovered in the circulation after transfusion with ACD whole blood stored for 24 hours, and after 72 hours there was a 20070 recovery, compared with 54070 with fresh blood. 3 Recent studies on the contribution of whole donor blood to circulating platelets are lacking. As an initial evaluation of the more modern methods of blood storage, we have reported that platelet counts are normal in whole donor blood which has been stored at 4 QC for one day.4 Even after three days' storage the counts are only slightly diminished. If the function of these platelets is even partly preserved, the use of whole blood after storage for short periods could reduce the need for platelet concentrates during blood replacement. It would also be a more efficient use of the platelets as about 50070 of the platelets in whole blood are lost during the production of platelet concentrates.
The aim of the present study was to evaluate platelet function in whole blood stored at 4 QC for one and three days, and compare this with the function of platelets stored as platelet concentrates at room temperature for the same periods of time. METHODS Six units of whole blood and six units of platelet concentrate were studied after storage for one day, and a further six units of each after storage for three days. Whole blood:
Blood for platelet aggregation was sampled from normal CPD blood units which had been stored at 4 QC for one and three days. Platelet-rich plasma (PRP) was prepared by centrifugation at 200 g for 11 minutes. Platelet-poor plasma (PPP) from the same blood was prepared by centrifugation at 1600 g for 15 minutes and used to adjust the platelet count of the PRP to 250,000/ Jil. The pH of the PRP measured at 37 QC was between 7.3 and 7.5. Platelet concentrates:
These were prepared from CPD blood by the South Australian Red Cross Blood Transfusion Service as for routine use. They were stored in Fenwal plastic bags and mixed by vertical rotation during storage at room temperature for one and three days. PRP was diluted to 250,000/ Jil with autologous PPP prepared as described above. The pH of the PRP (measured at 37 QC) was initially 6.4-7.4 and was adjusted to 7.3-7.5 by addition of 0.2 M/I sodium bicarbonate. The PRP was stored at 37 QC in an air-free syringe to maintain pH. 5 Platelet aggregation 6 was measured at 37 QC in a Pay ton dual channel aggregometer with a stirring speed of 500 rpm. Adenosine diphosphate (ADP), acid-soluble collagen,6 sodium arachidonate and ristocetin were used as the aggregating agents. Generally four concentrations of each aggregating agent were used to span the dose-response curve. The change in light transmission was recorded for five minutes and the maximum extent of aggregation calculated as a percentage of the difference between PRP and PPP.
Percent aggregation was plotted against the log of concentration of aggregating agent, and the dose to cause 50070 aggregation (A-50) was interpolated from the graph. Results were analysed by non-parametric ranking. Ranking was performed on the A-50 and where 50% aggregation was not achieved at any dose, the ranking was done in order of the maximum extent of aggregation.
Plasma f3-thromboglobulin (f3TG) was measured as previously described in samples of blood and platelet concentrate added to PGE Platelet A TP and ADP were extracted as described by Mills 9 and assayed by the method of Holmsen 10 with the following modifications: the phosphoenolpyruvate-pyruvate kinase mixture contained 8 mM/I Tris and 2 mM/I MgCI2.6H20, the dilution buffer used for standards and samples was tyrode: ethanol I: 1 and contained 2.5 mM/ I EDT A, incubations were at room temperature, and firefly luminescence was measured at room temperature in a Pay ton lumi-aggregometer_
RESULTS

1_ Platelet Shape
Platelet shape, whether discs or spiny spheres, can be assessed by the change in shape, measured as a change in light transmission, after the addition of ADP, particularly if the subsequent aggregation is blocked by prior addition of EGTA. 
Measurement of platelet shape in whole blood and platelet concentrates is shown in Figure 1_ The smaller measurements in the whole blood samples indicate that these platelets are less disc shaped (more spherical) than those in the platelet concentrates_ Also, there was a slight decrease in the degree of discoid shape in three-day-old concentrates compared with those from one day_ In whole blood but not platelet concentrates the platelets were more discoid after incubation at 37 QC for two hours, showing that some recovery of shape could occur during circulation in vivo_ 2. Platelet Aggregation a) ADP: None of the platelet concentrates stored for one or three days aggregated to 50070 even with concentrations of 10-4 and 10 -3 M/I. In contrast, the platelets from The difference between platelet concentrates and blood is highly significant for both one-and three-day storage (one-day storage, U = 0, p = <0.01; three-day storage, U =0, p<O.Ol). b) Collagen: Four of the platelet concentrates stored for one day aggregated to 50% with a collagen concentration of 12.6 /Ag/ml or lower as shown in Figure 3 (median A-50 7.5 /Ag/ml, range 5.2 to 9.5 /Ag/ml). After three days storage only one of the six . . Ristocetin mg/ml platelet concentrates achieved 50% aggregation. For one-day-old blood five units achieved 50% aggregation (median A-50 was 1.39 /Ag/ml, range l.l to 2.8 /Ag/ml). All of the units from three-dayold blood achieved 50% aggregation (median A-50 2.4 /Ag/ml, range 0.46 to 12.0/Ag/ml). The aggregation differences between platelet concentrates and whole blood after three days storage are significant (one-day storage, U = 6, 0.05<p<0.1O: three days storage, U = 1, p<O.OI). c) Sodium Arachidonate: For platelet concentrates only one unit achieved 50% aggregation and this was from one of the units stored for three days (Figure 4 ). In contrast, for whole blood, 50% The difference between platelet concentrates and whole blood was significant after three days' storage (U =4, p<0.05). d) Ristocetin: Both platelet concentrates and platelets from whole blood responded well to ristocetin except for one platelet concentrate stored for three days ( Figure  5 ). There were no significant differences between blood and platelet concentrates.
Nucleotide Content of Platelets
There was no difference in content of either ADP or A TP between blood and platelet concentrates stored for either one day or three days (Table 1) .
{3-thromboglobulin
After both one day and three days of storage, the platelets had liberated significantly more {3TG when stored as platelet concentrates than when stored as whole blood (Table 1 ). In both blood and platelet concentrates there was greater liberation at day 3 than at day 1.
DISCUSSION
At the present state of knowledge It IS not possible to predict accurately from in vitro tests the function of platelets after reinfusion. 8 On the other hand, neither do the in vivo tests, bleeding time and platelet survival necessarily accurately assess the contribution of transfused platelets to haemostasis. II Although prolonged platelet survival has been used to indicate suitability of platelets for transfusion purposes, platelets can survive normally but fail to function in vivo. 12 [t may well be that those platelets which survive longer have the most inhibited function and, that on the other hand, platelets which survive for only a short time may, during this brief interval, be functionally effective. 11 The test of in vitro function which most closely correlates with platelet survival is probably the discoid shape of the platelets and their ability to regain this shape when incubated under more optimal conditions. 8 The spiny sphered platelets which form during storage at 4 QC survive for. 1-3 days, whereas the more discoid platelets of 22 QC storage survive for 6-8 days.8 Platelets which have become spiny spheres may survive for only a short time but may be more reactive with vessel wall subendothelium II and hence more effective in haemostasis. Indeed, platelets stored at 4 QC have been shown to correct the bleeding time in thrombocytopenic patients l3 and in volunteers given aspirin. 14 ,15 Hence, the platelets from whole blood in the present study which retained their aggregation responses, but had lost their discoid shape, could be expected to survive for only a short period, but should be haemostatically effective. In the context of massive transfusion, a survival of even as short as 24 hours could well be adequate to assist significantly in haemostasis. In the present study the platelets showed loss of discoid shape when stored as whole blood at 4 QC compared with platelet concentrates at room temperature. There was a slight recovery towards a more discoid shape after incubation at 37 QC. This method may be more sensitive to such changes than electron microscopy by which Sturk et al. could find no recovery of shape when platelets stored at 4 QC were reincubated at 37 QC. 16 Platelet aggregation tests showed relatively good preservation of responses in whole blood after both one-and three-day storage. After one day of storage responses to all aggregating agents were virtually within our normal range for PRP tested as soon as possible after blood collection. For platelet concentrates a reduction in aggregation responses was observed, and this was most marked for ADP. Deficiency in this response could explain the lower response to collagen because this response is partially mediated by ADP. Reduced aggregation response to arachidonate of platelets from some units of whole blood and of platelet concentrate could be due to undocumented aspirin ingestion in the week preceding blood donation. This may have also had some effect on the responses to collagen, and to a lesser extent to ADP.
The nucleotide data showed that the platelets were metabolically intact in both platelet concentrates and in whole blood. This supports data from other workers for platelets stored as platelet concentrates. 8 The data for f3TG are of interest: it has been suggested that the liberation of f3TG from platelets stored as platelet concentrates may be a measure of the damage induced during the storage process. 17 We have data which show that platelet injury induced by storage conditions is associated with the release of f3TG from platelets in PRP. 6 The data from the present study show that when platelets were stored as whole blood there was less f3TG liberation than from platelets stored as platelet concentrates. Although this may indicate less injury, these results may only reflect the differences in storage temperature, since there is known to be less liberation of f3TG at 4 QC than at room temperature. 18 This paper presents evidence that platelets from whole blood stored for one and three days may well be capable of contributing to haemostasis. Although the platelets lost much of their discoid shape, there was some recovery of shape when they were incubated at 37 QC. Aggregation responses were well preserved, as was nucleotide content. There was less leakage of f3TG than in platelets stored as platelet concentrates. Thus overall the evidence suggests that the function of platelets in whole blood is well preserved, possibly even better than platelets stored as concentrate. If whole blood which is three days old or less was provided as replacement during massive transfusion, the platelets could be a significant contribution to haemostasis.
